Aizenstein M L, Segal D S, Kuczenski R
Department of Psychiatry, University of California, San Diego, La Jolla 92093.
Neuropsychopharmacology. 1990 Aug;3(4):283-90.
The repeated administration of amphetamine and related dopamine agonists results in an augmented or sensitized behavioral response to subsequent administration of these drugs. In addition to reflecting central nervous system plasticity, this altered response profile may also represent an animal model for stimulant-induced psychosis in humans. Therefore, considerable interest has been focused on determining the mechanisms underlying the sensitization process. One approach involves comparing and contrasting the effects of various stimulants possessing different molecular mechanisms of action. In this regard, some evidence suggests that fencamfamine and amphetamine interact with pharmacologically distinguishable dopamine pools. Therefore, we compared the behavioral response profiles to the repeated administration of behaviorally comparable doses of amphetamine and fencamfamine, and examined the pattern of cross-interaction between the two stimulants. Fencamfamine produced an amphetamine-like pattern of behavioral augmentation, and both drugs exhibited identical patterns of cross-sensitization. These results lend further support to the sensitization model of stimulant psychosis. Possible dopaminergic mechanisms underlying the sensitization are discussed.
反复给予苯丙胺及相关多巴胺激动剂会导致对这些药物后续给药的行为反应增强或敏感。除了反映中枢神经系统可塑性外,这种改变的反应模式也可能代表人类兴奋剂诱导精神病的动物模型。因此,相当多的研究兴趣集中在确定敏化过程的潜在机制上。一种方法是比较和对比具有不同分子作用机制的各种兴奋剂的作用。在这方面,一些证据表明芬坎法明和苯丙胺与药理学上可区分的多巴胺池相互作用。因此,我们比较了行为上相当剂量的苯丙胺和芬坎法明反复给药后的行为反应模式,并研究了两种兴奋剂之间的交叉相互作用模式。芬坎法明产生了类似苯丙胺的行为增强模式,并且两种药物表现出相同的交叉敏化模式。这些结果进一步支持了兴奋剂精神病的敏化模型。讨论了敏化潜在的可能多巴胺能机制。